PMID- 36066198 OWN - NLM STAT- MEDLINE DCOM- 20221103 LR - 20230205 IS - 1755-5949 (Electronic) IS - 1755-5930 (Print) IS - 1755-5930 (Linking) VI - 28 IP - 12 DP - 2022 Dec TI - The therapeutic potential of bone marrow-derived macrophages in neurological diseases. PG - 1942-1952 LID - 10.1111/cns.13964 [doi] AB - Circulating monocytes are precursors of both tissue macrophages and dendritic cells, and they can infiltrate the central nervous system (CNS) where they transform into bone marrow-derived macrophages (BMDMs). BMDMs play essential roles in various CNS diseases, thus modulating BMDMs might be a way to treat these disorders because there are currently no efficient therapeutic methods available for most of these neurological diseases. Moreover, BMDMs can serve as promising gene delivery vehicles following bone marrow transplantation for otherwise incurable genetic CNS diseases. Understanding the distinct roles that BMDMs play in CNS diseases and their potential as gene delivery vehicles may provide new insights and opportunities for using BMDMs as therapeutic targets or delivery vehicles. This review attempts to comprehensively summarize the neurological diseases that might be treated by modulating BMDMs or by delivering gene therapies via BMDMs after bone marrow transplantation. CI - (c) 2022 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. FAU - Zhou, Kai AU - Zhou K AUID- ORCID: 0000-0003-1026-757X AD - Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China. FAU - Han, Jinming AU - Han J AUID- ORCID: 0000-0002-6084-3275 AD - Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. FAU - Wang, Yafeng AU - Wang Y AD - Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China. AD - Department of Hematology and Oncology, Children's Hospital Affiliated to Zhengzhou University, Henan, Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China. FAU - Xu, Yiran AU - Xu Y AD - Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, The Third Affiliated Hospital and Institute of Neuroscience, Zhengzhou University, Zhengzhou, China. FAU - Zhang, Yaodong AU - Zhang Y AD - Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China. FAU - Zhu, Changlian AU - Zhu C AUID- ORCID: 0000-0002-5029-6730 AD - Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, The Third Affiliated Hospital and Institute of Neuroscience, Zhengzhou University, Zhengzhou, China. AD - Centre for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20220906 PL - England TA - CNS Neurosci Ther JT - CNS neuroscience & therapeutics JID - 101473265 SB - IM MH - Humans MH - *Macrophages MH - Central Nervous System MH - Monocytes MH - Bone Marrow Transplantation MH - *Central Nervous System Diseases PMC - PMC9627381 OTO - NOTNLM OT - bone marrow transplantation OT - dysfunctional microglia OT - gene delivery OT - gene therapy OT - macrophage OT - monocyte COIS- The authors declare no competing interest. EDAT- 2022/09/07 06:00 MHDA- 2022/11/04 06:00 PMCR- 2022/09/06 CRDT- 2022/09/06 08:43 PHST- 2022/08/19 00:00 [revised] PHST- 2022/05/30 00:00 [received] PHST- 2022/08/22 00:00 [accepted] PHST- 2022/09/07 06:00 [pubmed] PHST- 2022/11/04 06:00 [medline] PHST- 2022/09/06 08:43 [entrez] PHST- 2022/09/06 00:00 [pmc-release] AID - CNS13964 [pii] AID - 10.1111/cns.13964 [doi] PST - ppublish SO - CNS Neurosci Ther. 2022 Dec;28(12):1942-1952. doi: 10.1111/cns.13964. Epub 2022 Sep 6.